-
Abcam has chromatin and nuclear signalling antibodies
Abcam has an extensive range of chromatin and nuclear signalling antibodies encompassing cardiovascular, immunology and cell cycle research areas. More than 22,000 antibodies are available against proteins for ChIP, chromatin modification, chromatin remodelling, DNA methylation, histones, transcription and nuclear receptors.
-
ALBAcheck-BGS Sensitivity Controls
Alba Bioscience has added Anti-S (weak) to its range of control reagents namely, Anti-c (weak), Anti-Fya (weak), Anti-K (weak) and Anti-E (weak).
-
Lonza Potelligent CHOK1SV host cell line
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
-
Simplifying antibody conjugation processes
Innova Biosciences has developed a conjugation technology called Lightning-Link that eliminates almost all of the steps employed in a traditional conjugation process.
-
CD antibodies
Abcam has an extensive range of CD antibodies that are suitable for use in cancer, immunology, stem cell, endothelial and neuroscience research. Conjugated (allophycocyanin, FITC, phycoerythrin, biotin) and unconjugated antibodies are available.
-
High specificity clonal antibodies
DB Biotech has introduced a new technology for the production of highly specific RABBIT CLONAL antibodies. In vitro cloning technology developed by the company enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes.
-
Range of antibodies
Now available for the first time in Australia, the complete range of antibodies from Proteintech Group, Inc (PTG).
-
USP-NF compliant recombinant human albumins
Novozymes Biopharma has announced that its Recombumin and albucult products comply with the new excipient monograph standard for recombinant human albumin, published in the United States Pharmacopoeia — National Formulary (USP-NF). The monograph was first published in November 2008 and became official on 1 May 2009. As these products comply with the monograph, their use eases the regulatory process for users and sets the industry benchmark for recombinant human albumin.
-
Biorisk-free growth factors and cytokines
ORF Genetics offers high-grade, biorisk-free growth factors and hard-to-express recombinant proteins from ISOkine.
-
Infectious disease antibodies
The Abcam portfolio of antibodies for bacteriology, protozoa and infectious diseases includes antibodies against: Anthrax, Aspergillus, Cholera Toxin, Campylobacter, Chlamydia, Clostridium botulinum, Helicobacter pylori, Mycobacterium tuberculosis, Salmonella, Staphylococcus and Streptococcus.
-
Antibody range extended
Leica Microsystems has added seven more antibodies to the Bond RTU range which now includes more than 100 clinically relevant antibodies prepared for use on the fully automated Bond IHC and ISH system.
-
Antibodies, tissue slides and accessories
Abcam has an extensive range of fluorescent-conjugated and unconjugated antibodies for cancer, cardiovascular, cell biology, chromatin, developmental biology, immunology, neuroscience, nuclear signalling and stem cell research.
-
GPCR antibodies
G protein-coupled receptors (GPCRs) are one of the major classes of drug targets and an estimated 30-50% of all marketed drugs act on them. They are integral membrane receptors that transmit signals from various small molecules, peptides and lipids via G proteins where they affect many physiological functions in almost all organs.
-
Antibody range
The Bond RTU Antibodies range has been expanded with the Phase 8 release, which includes the antibodies Bcl-2 and Mismatch Repair Protein.
-
Polyubiquitin antibody
Biomol International has introduced a monoclonal antibody that specifically recognises K63-linked polyubiquitin, but not any other isopeptide-linked (K6, K11, K27, K29, K33 or K48) polyubiquitinylated species.
-
GPCR antibodies
G protein-coupled receptors (GPCRs) are one of the major classes of drug targets and an estimated 30-50% of all marketed drugs act on them.
-
Antibody learning website
Millipore has launched its Antibody Learning Center — a free web tool for navigating Millipore’s broad antibody portfolio and planning efficient workflows for immunodetection in protein research.
-
Antibodies
Prestige Antibodies, powered by Atlas Antibodies, are developed and validated by the Human Proteome Resource (HPR) project.
-
Protease Inhibitor Library
The Screen-Wellâ„¢ Protease Inhibitor Library from BIOMOL International includes 53 known protease inhibitors on a single 96-well plate.
-
Non-animal organic lac operon inducer
An animal-free IPTG (isopropyl-beta-D-galactopyranoside) is available from BioVectra.
-
Cytokine kits
Abcam has released a range of ELISA, Elispot, Fluorospot and Eupair kits for use in research on cytokines, CD markers, cytokine receptors, adhesion molecules and apoptosis proteins. These kits are supplied in a range of sizes, with or without plates. Further sizes of kits, some with sterile plates, are in development for multiple targets.
-
Fluorescent secondary antibodies and streptavidin conjugates
NorthernLights (from R&D Systems) fluorescent secondary antibodies and streptavidin conjugates are bright and resistant to photobleaching.
-
FK1 and FK2 Horseradish Peroxidase Conjugates
In order to investigate the status and extent of protein ubiquitinylation, it is necessary to have available a range of antibodies capable of differentiating firstly between free ubiquitin and ubiquitin-protein conjugates and, secondly, between those that are monoubiquitinylated and those that are polyubiquitinylated.
© 2010 Westwick-Farrow Pty Ltd. All Rights Reserved. Designated trademarks and brands are the property of their respective owners. Use of this website constitutes acceptance of our
Terms and Conditions
and
Privacy Policy.